血浆生长分化因子15水平与未来静脉血栓栓塞风险相关
在Tromsø研究基础上的人群巢式病例对照研究中,416例静脉血栓栓塞(VTE)患者与848名年龄性别匹配对照显示,GDF-15最高四分位组(≥358 pg/mL)较低四分位组(<200 pg/mL)VTE的OR为2.05(95%CI 1.37-3.08)。孟德尔随机化分析未提示GDF-15水平与VTE存在因果关联。
要点
- GDF-15最高四分位组(≥358 pg/mL)VTE风险较低四分位组(<200 pg/mL)升高,OR 2.05(95%CI 1.37-3.08)。
- GDF-15四分位间VTE的OR呈递增趋势(P趋势=.002)。
- 孟德尔随机化分析未提示GDF-15水平与VTE存在因果关联。
核心结论
- 高GDF-15水平与VTE风险增加相关,但孟德尔随机化分析提示该关联并非因果。
研究设计与样本
- 基于Tromsø研究的人群巢式病例对照研究,纳入416例VTE患者和848名年龄性别匹配对照。
- 采用logistic回归计算GDF-15四分位间VTE的OR。
- 孟德尔随机化分析使用国际静脉血栓网络(INVENT)联盟数据,检验全基因组显著水平的GDF-15相关单核苷酸多态性(SNP)是否与VTE相关。
主要发现
- GDF-15四分位间VTE的OR呈递增趋势(P趋势=.002)。
- 年龄性别校正模型中,GDF-15最高四分位组(≥358 pg/mL)较低四分位组(<200 pg/mL)VTE的OR为2.05(95%CI 1.37-3.08)。
- 进一步校正体重指数、吸烟、激素治疗、体力活动和C反应蛋白后,OR基本不变。
- 在诱发性/非诱发性事件、深静脉血栓和肺栓塞中观察到相似结果。
- 孟德尔随机化分析中,由SNP预测的GDF-15水平与VTE不相关。
关键数值与推荐
- GDF-15最高四分位组(≥358 pg/mL)较低四分位组(<200 pg/mL)VTE的OR为2.05(95%CI 1.37-3.08),年龄性别校正模型。
- GDF-15四分位间VTE的OR趋势检验P趋势=.002。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Growth differentiation factor 15 (GDF-15), a marker of inflammation and oxidative stress, has emerged as a biomarker for arterial cardiovascular disease. However, the association between GDF-15 and venous thromboembolism (VTE) remains uncertain. We therefore investigated the association between plasma GDF-15 levels and future risk of incident VTE and explored the potential of a causal association using Mendelian randomization (MR). We conducted a population-based nested case-control study comprising 416 VTE patients and 848 age- and sex-matched controls derived from the Tromsø Study. Logistic regression was used to calculate odds ratios (ORs) for VTE across GDF-15 quartiles. For the MR, we used data from the International Network on Venous Thrombosis (INVENT) consortium to examine whether single nucleotide polymorphisms (SNPs) associated with GDF-15 levels with genome-wide significance were related to VTE. We found that the ORs for VTE increased across GDF-15 quartiles (Ptrend = .002). Participants with GDF-15 values in the highest quartile (≥358 pg/mL) had an OR for VTE of 2.05 (95% confidence interval, 1.37-3.08) compared with those with GDF-15 in the lowest quartile (<200 pg/mL) in the age- and sex-adjusted model. ORs remained essentially the same after further adjustment for body mass index, smoking, hormone therapy, physical activity, and C-reactive protein. Similar results were obtained for provoked/unprovoked events, deep vein thrombosis, and pulmonary embolism. GDF-15 levels, as predicted by the SNPs, were not associated with VTE in MR. Our results indicate that high GDF-15 levels are associated with increased risk of VTE, but MR suggests that this association is not causal.
引用
- Hansen ES, Hindberg K, Latysheva N, et al. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism. Blood. 2020. PMID: 32645137. doi:10.1182/blood.2019004572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。